Free Signup

Allogeneic matrix

OVERVIEW

Allogeneic Matrices are usually derived from human neonatal fibroblasts of the foreskin that may contain metabolically active or regenerative components primarily used for soft tissue support, though some have been approved for the treatment of full-thickness skin and soft tissue loss. Most are biodegradable and disappear after 3-4 weeks implantation. [1] This category also includes cellular and/or tissue products (also known as skin substitutes) derived from amnion, chorion, placenta or umbilical cord that have not been decellularized. 

Official reprint from WoundReference® woundreference.com ©2018 Wound Reference, Inc. All Rights Reserved

REFERENCES

  1. Administrators, CGS et al. Local Coverage Determination (LCD) - Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities (L36690) . Date of publication 2017 Oct 7;volume ():.

SUBTOPICS